首页|枸橼酸对CRRT治疗脓毒症休克患者肾搏动指数及凝血功能水平的影响

枸橼酸对CRRT治疗脓毒症休克患者肾搏动指数及凝血功能水平的影响

扫码查看
目的:探究枸橼酸对连续性肾脏替代治疗(CRRT)对脓毒症休克患者肾搏动指数及凝血功能水平的影响.方法:选取 2020 年1 月—2022 年 12月间就诊本院的 90 例脓毒症休克患者为受试对象,采用动态随机划分为对照组(n=45)与观察组(n=45).两组患者均予以CRRT治疗,血流量速率设置为180 ml/min,透析液流速 2000 ml/h.对照组予以肝素钠注射液抗凝(先取 4ml肝素钠注射液与 250 ml氯化钠注射液配比混合静脉注射;后取 16 ml肝素钠注射液与 1 000 ml氯化钠注射液配比混合静脉滴注).观察组予以枸橼酸钠抗凝(每 1 000 ml输血量搭配 10%葡萄糖酸钙10 ml进行中和静脉注射),两组均持续给药至CRRT治疗结束前 1.5 h.比较两组患者治疗前及治疗 7d后肾动力学参数[肾搏动指数(RPI)、肾阻力指数(RRI)]、肾功能[血尿素氮(BUN)、血清肌酐(Scr)]、凝血功能[凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)]、肝功能[丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素(TBil)]变化;统计比较治疗 7d后滤器平均使用寿命、不良反应发生率.结果:治疗前两组患者各项指标比较均无统计学差异(P>0.05).治疗 7d后,两组患者肾动力学参数(RPI、PPI)、肾功能指标(BUN、Scr)、肝功能指标(ALT、AST、TBil)水平均有下降,且观察组显著低于同时期对照组(P<0.05);凝血功能(PT、TT、APTT)均有升高,且观察组显著高于同时期对照组(P<0.05);观察组滤器使用寿命显著高于对照组,且不良反应发生率低于对照组(P<0.05).结论:枸橼酸钠在CRRT治疗脓毒症休克患者时,不仅可以调节患者肾搏动指数和凝血状态,还能保护肝肾功能、延长滤器使用寿命,提高治疗安全性.
Effects of citrate on renal pulsatility index and coagulation function in patients with septic shock treated with CRRT
Objective:To explore the effects of citrate on renal pulsatility index and coagulation function in patients with septic shock treated with continuous renal replacement therapy(CRRT).Methods:Ninety patients with septic shock who vis-ited our hospital between January 2020 and December 2022 were selected as subjects and were divided into the control group(n=45)and observation group(n=45)using dynamic randomization.Both groups were treated with CRRT,with a blood flow rate set at 180 ml/min and a dialysate flow rate of 2 000 ml/h.The control group was anticoagulated with heparin sodium injection[4 ml of heparin sodium injection mixed with 250 ml of sodium chloride injection intravenously,followed by 16 ml of heparin sodium injection mixed with 1 000 ml of sodium chloride injection intravenously].The observation group was given sodium citrate anticoagulation[10 ml of 10%calcium gluconate per 1 000 ml of blood transfusion for neutralization intravenously],which was continued in both groups until 1.5 h before the end of CRRT treatment.Renal dynamic parameters[renal pulsatility index(RPI),renal resistance index(RRI)],renal function[blood urea nitrogen(BUN),serum creatinine(Scr)],coagulation function[prothrombin time(PT),thrombin time(TT),activated partial thromboplastin time(APTT)]and liver function[alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TBil)]were compared between the two groups before treatment and after seven days of treatment.The average service life of the filter and the inci-dence rate of adverse reactions were statistically compared after seven days of treatment.Results:There was no statistically significant difference in comparing the indicators between the two groups of patients before treatment(P>0.05).After seven days of treatment,the levels of renal kinetic parameters(RPI,PPI),renal function indexes(BUN,Scr),and hepatic function indexes(ALT,AST,TBil)of patients in the two groups decreased,and the observation group was significantly lower than the control group in the same period(P<0.05).Coagulation function(PT,TT,APTT)increased,and the observation group was sig-nificantly higher than the control group in the same period(P<0.05).The service life of filters in the observation group was significantly higher than the control group,and the incidence of adverse reactions was lower than the control group(P<0.05).Conclusion:Sodium citrate can not only regulate the patients'renal pulsatility index and coagulation status when treating sep-tic shock patients with CRRT but also protect liver and kidney functions,prolong filter life,and improve treatment safety.

citrateseptic shockrenal pulsatility indexcoagulation functionCRRT

钟雪飞、艾青涯、沈锦明

展开 >

新余市人民医院,江西 338000

枸橼酸 脓毒症休克 肾搏动指数 凝血功能 CRRT

2024

天津药学
天津市医药集团有限公司 天津市药学会

天津药学

影响因子:0.794
ISSN:1006-5687
年,卷(期):2024.36(1)
  • 18